Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/70782
Título: | Paying for pharmaceuticals: uniform pricing versus two-part tariffs |
Autor(es): | Brekke, Kurt R. Dalen, Dag Morten Straume, Odd Rune |
Palavras-chave: | Pharmaceuticals Health Plans Payment schemes |
Data: | 2021 |
Editora: | Universidade do Minho. Núcleo de Investigação em Políticas Económicas (NIPE) |
Resumo(s): | Two-part pricing (the Netflix model) has recently been proposed instead of uniform pricing for pharmaceuticals. Under two-part pricing the health plan pays a fixed fee for access to a drug at unit prices equal to marginal costs. Despite two-part pricing being socially efficient, we show that the health plan is worse off when the drug producer is a monopolist, as all surplus is extracted. This result is reversed with competition, as two-part pricing yields higher patient utility and lower drug costs for the health plan. However, if we allow for exclusive contracts, uniform pricing is preferred by the health plan. |
Tipo: | Documento de trabalho |
URI: | https://hdl.handle.net/1822/70782 |
Versão da editora: | https://www.eeg.uminho.pt/pt/investigar/nipe/Paginas/publicacoes.aspx |
Arbitragem científica: | no |
Acesso: | Acesso aberto |
Aparece nas coleções: | NIPE - Documentos de Trabalho |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
WP 1 2021.pdf | Paying for pharmaceuticals: uniform pricing versus two-part tariffs | 868,61 kB | Adobe PDF | Ver/Abrir |